| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 266,6 k € | +16.4% | 229,1 k € | -26.3% | 310,8 k € | -5.0% | 327,3 k € | -15.7% | 388,5 k € | +27.3% | 305,1 k € | +13.9% | 267,8 k € | +5.5% | 253,9 k € | +11.7% | 227,3 k € | -7.1% | 244,8 k € | +9.3% | 223,9 k € | +19.2% | 187,8 k € | -13.5% | 217,1 k € | +38.5% | 156,7 k € | -36.0% | 244,8 k € | +10.0% | 222,5 k € | -26.7% | 303,4 k € | +23.1% | 246,5 k € | -9.5% | 272,5 k € | |
| EBITDA | 262,6 k € | +16.5% | 225,4 k € | -26.6% | 307,3 k € | -5.3% | 324,4 k € | -15.6% | 384,1 k € | +27.3% | 301,7 k € | +14.2% | 264,3 k € | +5.7% | 250,1 k € | +11.9% | 223,6 k € | -7.1% | 240,6 k € | +9.2% | 220,4 k € | +19.8% | 183,9 k € | -13.2% | 211,8 k € | +41.1% | 150,1 k € | -36.7% | 237,1 k € | +9.7% | 216,2 k € | -14.5% | 252,9 k € | +32.0% | 191,6 k € | -11.9% | 217,5 k € | |
| Operating profit | 238,4 k € | +18.0% | 202,1 k € | -28.8% | 284,0 k € | -4.5% | 297,4 k € | -15.2% | 350,9 k € | +37.5% | 255,3 k € | +17.3% | 217,8 k € | +18.1% | 184,4 k € | +16.6% | 158,1 k € | +43.4% | 110,2 k € | -32.1% | 162,4 k € | +2666.4% | 5,9 k € | -96.8% | 183,6 k € | +49.1% | 123,1 k € | -37.0% | 195,2 k € | +10.7% | 176,4 k € | -17.9% | 214,8 k € | +39.0% | 154,5 k € | -14.2% | 180,1 k € | |
| Profit/loss | 177,6 k € | +25.4% | 141,6 k € | -28.5% | 198,0 k € | -1.6% | 201,2 k € | -13.6% | 232,9 k € | +50.7% | 154,6 k € | +9.0% | 141,8 k € | +34.2% | 105,6 k € | +9.2% | 96,8 k € | +94.3% | 49,8 k € | -51.6% | 103,0 k € | +377.9% | -37,0 k € | -121.4% | 173,4 k € | +28.6% | 134,8 k € | -19.7% | 167,9 k € | +47.3% | 114,0 k € | -4.1% | 118,8 k € | +18.7% | 100,1 k € | -30.1% | 143,2 k € | |
| Equity | 970,2 k € | +0.3% | 966,8 k € | -9.4% | 1,1 M € | -15.3% | 1,3 M € | +19.0% | 1,1 M € | +28.2% | 826,8 k € | +23.0% | 672,2 k € | -46.0% | 1,2 M € | +9.3% | 1,1 M € | +9.3% | 1,0 M € | +5.0% | 993,7 k € | +466.9% | 175,3 k € | -82.6% | 1,0 M € | +20.8% | 834,0 k € | +19.3% | 699,2 k € | +31.6% | 531,3 k € | +27.3% | 417,3 k € | +30.5% | 319,9 k € | -35.3% | 494,8 k € | |
| Total assets | 1,3 M € | -5.4% | 1,3 M € | +8.3% | 1,2 M € | -24.0% | 1,6 M € | +6.3% | 1,5 M € | -5.0% | 1,6 M € | +2.8% | 1,5 M € | -15.8% | 1,8 M € | -0.2% | 1,8 M € | -3.1% | 1,9 M € | +68.0% | 1,1 M € | +10.4% | 1,0 M € | -4.7% | 1,1 M € | +17.0% | 917,0 k € | +18.5% | 774,2 k € | +16.9% | 662,1 k € | -8.3% | 722,3 k € | +7.9% | 669,4 k € | +11.5% | 600,1 k € | |
| Cash | 256,9 k € | +75.0% | 146,9 k € | -65.9% | 430,2 k € | -45.7% | 791,6 k € | +7.2% | 738,5 k € | +161.3% | 282,7 k € | +48.0% | 191,0 k € | +35.0% | 141,5 k € | -8.9% | 155,3 k € | +95.3% | 79,5 k € | -76.7% | 341,4 k € | +17.5% | 290,5 k € | — | — | — | — | 6,9 k € | -50.7% | 14,0 k € | +0.8% | 13,9 k € | ||||||
| Debts | 190,1 k € | -27.7% | 262,8 k € | +303.3% | 65,2 k € | -73.1% | 242,1 k € | -37.0% | 384,6 k € | -44.6% | 694,4 k € | -13.9% | 806,4 k € | +54.8% | 520,9 k € | -17.0% | 627,5 k € | -20.5% | 788,9 k € | +1023.0% | 70,3 k € | -91.0% | 782,2 k € | +443155.0% | 176,5 € | -99.0% | 17,7 k € | +82.3% | 9,7 k € | -85.8% | 68,5 k € | -72.1% | 245,5 k € | -16.1% | 292,7 k € | +445.4% | 53,7 k € | |
| Staff | — | — | — | — | — | — | — | — | — | — | — | — | 0,1 | 0,1 | 0,1 | — | 1 | 1 | 1 | |||||||||||||||||||
Private limited company · Nieuwpoort · incorporated on 04/10/2000
Private limited company profitable and well capitalised. Cash position rising (+75.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DOKTER BAERT is a Private limited company incorporated in 2000. Its main activity is: General medical practice activities. Its registered office is in Nieuwpoort.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette